To understand physician preferences and bleeding complication rates of intramuscular botulinum neurotoxin type A injections for spasticity management in anticoagulated patients, questionnaires were mailed to 138 physicians across Canada. The international normalized ratio comfort range for injections was <2.0 in 10%, 2.0 to 2.5 in 35%, 2.6 to 3.0 in 25%, and 3.1 to 3.5 in 20% of physicians. Only 23% injected outside their comfort value and 57% did not; 72% did not normalize the international normalized ratio value before injections. Only one injector reported the development of compartment syndrome. As expected, high variability exists in physician preferences in botulinum neurotoxin type A injection in anticoagulated patients.RÉSUMÉ: Préférences des médecins en ce qui a trait aux injections de toxine botulinique données à des patients atteints de spasticité et recevant un traitement anticoagulant. Pour connaître les préférences des médecins ainsi que le taux de complications hémorragiques en ce qui a trait aux injections intramusculaires de toxine botulinique de type A données à des patients traités pour la spasticité et recevant un traitement anticoagulant, des questionnaires ont été envoyés à 138 médecins aux quatre coins du Canada. Les seuils d'acceptabilité de taux de prothrombine (TP) étaient <2,0 pour 10% des médecins; 2,0 à 2,5 pour 35% d'entre eux; 2,6 à 3,0 pour 25% d'entre eux; et finalement 3,1 à 3,5 pour 20% d'entre eux. Seulement 23% des médecins ont procédé à des injections au-delà de leur seuil d'acceptabilité tandis que 57% d'entre eux s'y sont refusés. Enfin, 72% des médecins n'ont pas normalisé le seuil d'acceptabilité de TP avant de procéder à des injections. Fait à noter, seul un médecin a signalé l'apparition d'un syndrome des loges. Comme on pouvait s'y attendre, il existe chez les médecins une forte variabilité de préférences en ce qui regarde l'injection de toxine botulinique de type A chez des patients recevant un traitement anticoagulant.
Artificial Intelligence (AI) is poised to revolutionize the way in which medicine is practiced and thereby transform how healthcare is delivered. While in its nascence in terms of medical applications, it is imperative that the healthcare community plays an active role in helping co-design platforms for the future. This article outlines the Canadian context of AI development by touching on its history and current utility. It also outlines the importance of capital investment, sustainable design, and how Canada has a unique opportunity to be a global leader in AI infrastructure development.
Compared to controls, response time was significantly impaired among LH and RH when the response could not be pre-programmed. While current simple RT testing commonly employed by driver rehab specialists may be sufficient for detecting RT deficits in patients with RH, simple or dual-task RT tests alone may fail to detect RT deficiencies among LH, even when testing the non-paretic limb. Choice RT should be added to post-stroke driver fitness assessment, particularly for patients with LH.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.